Bioaerosols, Disease, and Toxicity: What Does Science Tell Us

2 Hours 55 Minutes
SKU: 10ACOEM-2311

Track: Environmental Health and Risk Management

Michael J. Hodgson, MD, MPH*, Veterans Health Administration, Washington, DC

Harriet M. Ammann, PhD, University of Washington School of Public Health, Seattle, WA
David J. Miller, PhD, Carleton University, Ottawa, Ontario, Canada

The many reviews in the peer-reviewed literature on bioaerosols, human disease, and [myco]toxins generally failed to cite the pertinent scientific literature and mostly quote each of their predecessors reviewing a limited set of pertinent publications. This session will present an evidence-based broad summary of disease and known pertinent mechanisms and diagnostic criteria; toxicological literature on dose, route of exposure, location of toxicity, and risk assessment; and public health practice implications, including the limitations of science, appropriate intervention strategies in the presence of uncertainty, and the consequences of failure to act.

Product speakers